| Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival DJ Kwekkeboom, WW de Herder, BL Kam, CH van Eijck, M van Essen, ... Journal of Clinical Oncology 26 (13), 2124-2130, 2008 | 1695 | 2008 |
| Cushing's syndrome A Lacroix, RA Feelders, CA Stratakis, LK Nieman The lancet 386 (9996), 913-927, 2015 | 908 | 2015 |
| Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors DJ Kwekkeboom, JJ Teunissen, WH Bakker, PP Kooij, WW de Herder, ... Journal of Clinical Oncology 23 (12), 2754-2762, 2005 | 819 | 2005 |
| Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate DJ Kwekkeboom, WH Bakker, BL Kam, JJM Teunissen, PPM Kooij, ... European journal of nuclear medicine and molecular imaging 30, 417-422, 2003 | 517 | 2003 |
| Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors T Brabander, WA van der Zwan, JJM Teunissen, BLR Kam, RA Feelders, ... Clinical Cancer Research 23 (16), 4617-4624, 2017 | 509 | 2017 |
| The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics E Valassi, A Santos, M Yaneva, M Tóth, CJ Strasburger, P Chanson, ... European journal of endocrinology 165 (3), 383-392, 2011 | 405 | 2011 |
| Thyroid hormone concentrations, disease, physical function, and mortality in elderly men AW van den Beld, TJ Visser, RA Feelders, DE Grobbee, SWJ Lamberts The Journal of Clinical Endocrinology & Metabolism 90 (12), 6403-6409, 2005 | 386 | 2005 |
| Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection F Beuschlein, J Weigel, W Saeger, M Kroiss, V Wild, F Daffara, R Libé, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 841-849, 2015 | 335 | 2015 |
| Glucocorticoid sensitivity in health and disease RA Quax, L Manenschijn, JW Koper, JM Hazes, SWJ Lamberts, ... Nature Reviews Endocrinology 9 (11), 670-686, 2013 | 330 | 2013 |
| Cushing’s syndrome: epidemiology and developments in disease management ST Sharma, LK Nieman, RA Feelders Clinical epidemiology, 281-293, 2015 | 324 | 2015 |
| The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5 LJ Hofland, J van der Hoek, R Feelders, MO van Aken, PM van Koetsveld, ... European Journal of Endocrinology 152 (4), 645-654, 2005 | 310 | 2005 |
| Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease RA Feelders, C de Bruin, AM Pereira, JA Romijn, RT Netea-Maier, ... New England Journal of Medicine 362 (19), 1846-1848, 2010 | 295 | 2010 |
| Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly J Feenstra, WW De Herder, S Ten Have, AW Van den Beld, RA Feelders, ... The Lancet 365 (9471), 1644-1646, 2005 | 275 | 2005 |
| Risk factors for hemodynamic instability during surgery for pheochromocytoma H Bruynzeel, RA Feelders, THN Groenland, AH Van Den Meiracker, ... The Journal of Clinical Endocrinology & Metabolism 95 (2), 678-685, 2010 | 255 | 2010 |
| The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro LJ Hofland, J van der Hoek, PM van Koetsveld, WW de Herder, ... The Journal of Clinical Endocrinology & Metabolism 89 (4), 1577-1585, 2004 | 229 | 2004 |
| Structure, function and clinical significance of transferrin receptors RA Feelders, EPA Kuiper-Kramer, HG van Eijk Walter de Gruyter 37 (1), 1-10, 1999 | 229 | 1999 |
| Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant S Neggers, MO Van Aken, WW De Herder, RA Feelders, J Janssen, ... The Journal of Clinical Endocrinology & Metabolism 93 (10), 3853-3859, 2008 | 201 | 2008 |
| Effects of therapy with [177Lu-DOTA0, Tyr3] octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma M van Essen, EP Krenning, PP Kooij, WH Bakker, RA Feelders, ... Journal of nuclear medicine 47 (10), 1599-1606, 2006 | 201 | 2006 |
| Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study DJF Stuijver, B van Zaane, RA Feelders, J Debeij, SC Cannegieter, ... The Journal of Clinical Endocrinology & Metabolism 96 (11), 3525-3532, 2011 | 193 | 2011 |
| A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients J van der Hoek, WW de Herder, RA Feelders, AJ van der Lely, ... The Journal of Clinical Endocrinology & Metabolism 89 (2), 638-645, 2004 | 182 | 2004 |
